Whipplewood Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-72
Closed -$541 1213
2024
Q4
$541 Buy
+72
New +$541 ﹤0.01% 1104